On June 27, 2018, at the conference hall of the Heart Institute of the Ministry of Health of Ukraine, a meeting of doctors and patients with the famous Indian transplant doctor Dr. Komarakshi Balakishnan was held. In 2010, he transplanted the first heart, and now more than 250 transplants have been in the account, dozens of the heart transplantation surgeries were conducted on children.
Dr. Balakrishnan is a recognized expert in the treatment of heart failure at the terminal stage. He was the first to introduce the implantation of the mechanical hearts LVAD and HVAD as a therapy for patients who are expecting heart transplantation, actively contributed to the establishment of a center to treat heart failure at the Fortis Malar Hospital in Chennai, India, he is also one of the top ten best transplanters in the world.
During the meeting, the issues of the early postoperative stage of patient management after transplantation and implantation of the mechanical heart were discussed. The participants received copies of protocols for patient management in the intensive care and in-patient departments. In his speech, Dr. K. R. Balakrishnan paid special attention to the complications that arise in the remote postoperative period and shared his experience of their recognition and treatment with the present practitioners.
The lecture which K. R. Balakrishnan devoted to the protocols of managing patients after the heart transplantation in the remote postoperative period was particularly interesting. This topic raised an animated discussion and a series of questions from both the practitioners and the patients after heart transplantation.
After the presentation, Dr. K. R. Balakrishnan began a review of patients with the heart transplant. The review lasted until late in the evening, and each patient could personally talk with Dr. K. R. Balakrishnan, go through the echocardiogram, receive useful information and recommendations.
The Heart Institute team is grateful to Dr. K. R. Balakrishnan for his recommendations for post-transplant patients and access to invaluable experience from the transplant program that has been successfully run in India for more than 20 years.